Stankovich Thomas

Chief Financial OfficerReShape Lifesciences Inc. (RSLS) · full profile →Form 4 · filed Jun 1, 2022
Net Buying
Open-Market Buys
$18K
Open-Market Sells
$0
Net Open-Market Flow
$18K
Transactions
8
8 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 31, 2022Buy(P)1K$0.95$1K366K
May 31, 2022Buy(P)7K$0.94$6K364K
May 31, 2022Buy(P)60$0.93$56358K
May 31, 2022Buy(P)8K$0.92$7K358K
May 31, 2022Buy(P)1K$0.90$900350K
May 31, 2022Buy(P)200$0.89$178349K
May 31, 2022Buy(P)3K$0.88$3K349K
May 31, 2022Buy(P)78$0.87$68346K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-067045) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Ask your agent about RSLS insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001104659-22-067045"
Ask your agent
Use Arkolith to summarize insider buying and selling at ReShape Lifesciences Inc.
over the last 90 days and cite the filings.